SCHEMBL4349504

SCHEMBL4349504

O=C(NC1CCCCC1)N(S)c1cc(Br)cc(F)c1O

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.39
RAB9A P51151 7/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 2/20 0.38
EPHX1 P07099 1/20 0.38
POLB P06746 1/20 0.38
PKM P14618 1/20 0.37
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
EPHX2 P34913 2/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27761096 0.85 PKM (0.49) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL4347205 0.81 MEN1 (0.43) NPC1RAB9AALDH1A1KMT2AMEN1
SCHEMBL4354007 0.81 NPC1 (0.46) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL4341989 0.80 PKM (0.44) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL4357800 0.78 EPHX2 (0.48) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL4351731 0.76 PTGES (0.36) KDM4EALDH1A1
SCHEMBL4350103 0.76 PKM (0.43) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL4354698 0.75 CYP2C19 (0.47) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL4341456 0.75 NPC1 (0.41) NPC1RAB9ASMN1; SMN2GAAKMT2A
SCHEMBL28784044 0.74 LMNA (0.38) NPC1RAB9ASMN1; SMN2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 NPC1 815/4885RAB9A 4228/4885SMN1; SMN2 1791/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 NPC1 1189/4885RAB9A 4588/4885SMN1; SMN2 3250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.